e.g. Filippa Pettersson or Cancer Res. 75(6) , 1102-12, (2015) or 10.1002/anie.201600521
Bioorganic & Medicinal Chemistry 2006-06-01
Synthesis, docking, and in vitro activity of thiosemicarbazones, aminoacyl-thiosemicarbazides and acyl-thiazolidones against Trypanosoma cruzi.
Ana Cristina Lima Leite, Renata Souza de Lima, Diogo Rodrigo de M Moreira, Marcos Veríssimo de O Cardoso, Ana Carolina Gouveia de Brito, Luciene Maria Farias Dos Santos, Marcelo Zaldini Hernandes, Alice Costa Kiperstok, Ricardo Santana de Lima, Milena B P Soares
A novel series of thiosemicarbazone and aminoacyl-thiazolidones derivatives were synthesized. Their structure suggests that these compounds could have anti-Trypanosoma cruzi activity. Biological evaluation indicates that some of these compounds are able to inhibit the growth of T. cruzi in concentrations non-cytotoxic to mammalian cells. Docking studies were carried out in order to investigate the binding pattern of these compounds for the T. cruzi cruzain (TCC) protein, and these showed a significant correlation with experimental data.